Jonathan Schultz - Intermolecular Director
Director
Mr. Jonathan B. Schultz is the Independent Director of the company. He was the managing principal of Onyx Equities, LLC, a leading real estate investment and property services firm specializing in acquiring and managing commercial properties, since he cofounded it in 2005. Mr. Schultz also has served on the board of trustees of the Riverview Medical Center Foundation since 2014 since 2018.
| Age | 52 |
| Tenure | 6 years |
| Phone | 408 582-5700 |
| Web | www.intermolecular.com |
Intermolecular Management Efficiency
The company has Return on Asset of 12.76 % which means that on every $100 spent on assets, it made $12.76 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 35.45 %, implying that it generated $35.45 on every 100 dollars invested. Intermolecular's management efficiency ratios could be used to measure how well Intermolecular manages its routine affairs as well as how well it operates its assets and liabilities.The company has 13.65 M in debt with debt to equity (D/E) ratio of 49.1, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Intermolecular has a current ratio of 4.65, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Intermolecular until it has trouble settling it off, either with new capital or with free cash flow. So, Intermolecular's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intermolecular sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intermolecular to invest in growth at high rates of return. When we think about Intermolecular's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Randall Waterfield | Asure Software | 43 | |
| Rainer Jueckstock | Plexus Corp | 58 | |
| Jeffrey Graham | NETGEAR | 62 | |
| Grady Summers | NETGEAR | 39 | |
| Shay David | Kaltura | 51 | |
| Daniel Gill | Asure Software | 53 | |
| Stephen Cortinovis | Plexus Corp | 67 | |
| Bradley Maiorino | NETGEAR | 47 | |
| Joann Eisenhart | Plexus Corp | 58 | |
| Timothy Godwin | NETGEAR | 64 | |
| David Drury | Plexus Corp | 69 | |
| Jef Graham | NETGEAR | 60 | |
| Ralf Boer | Plexus Corp | 70 | |
| Paul Rooke | Plexus Corp | 59 | |
| Thomas Waechter | NETGEAR | 64 | |
| Brad Burrows | Asure Software | N/A | |
| Adrian Pertierra | Asure Software | 45 | |
| Christopher Genualdi | NETGEAR | N/A | |
| Mary Winston | Plexus Corp | 52 | |
| Charles Lathrop | Asure Software | 61 | |
| Michael Schrock | Plexus Corp | 64 | |
Management Performance
| Return On Equity | 35.45 | |||
| Return On Asset | 12.76 |
Intermolecular Leadership Team
Elected by the shareholders, the Intermolecular's board of directors comprises two types of representatives: Intermolecular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intermolecular. The board's role is to monitor Intermolecular's management team and ensure that shareholders' interests are well served. Intermolecular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intermolecular's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christian Kramer, President CEO | ||
| Thomas Baruch, Independent Director | ||
| Kenneth Traub, Independent Director | ||
| Jonathan Schultz, Director | ||
| C Neely, CFO, Principal Financial and Accounting Officer | ||
| Bruce McWilliams, Chairman, CEO and Pres | ||
| Matthew Furnas, Director | ||
| Bill Roeschlein, CFO, Principal Financial & Principal Accounting Officer | ||
| Irwin Federman, Independent Director | ||
| Adam Scheer, Director | ||
| George Scalise, Independent Director | ||
| Scot Griffin, Sr. VP of Bus. Operations and Corporate Secretary | ||
| Marvin Burkett, Independent Director |
Intermolecular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intermolecular a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 35.45 | |||
| Return On Asset | 12.76 | |||
| Profit Margin | 12.89 % | |||
| Operating Margin | (45.02) % | |||
| Current Valuation | 49.2 M | |||
| Shares Outstanding | 49.76 M | |||
| Shares Owned By Insiders | 30.13 % | |||
| Shares Owned By Institutions | 0.37 % | |||
| Number Of Shares Shorted | 4.43 K | |||
| Price To Earning | (3.08) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Intermolecular Stock
If you are still planning to invest in Intermolecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intermolecular's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets |